BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 8136104)

  • 1. Localizing value of catecholamine profile in patients with adrenal or ectopic pheochromocytoma.
    Azizi M; Day M; Plouin PF
    Am J Hypertens; 1994 Jan; 7(1):110-1. PubMed ID: 8136104
    [No Abstract]   [Full Text] [Related]  

  • 2. Plasma neuropeptide Y and catecholamine concentrations and urinary metanephrine excretion in patients with adrenal or ectopic phaeochromocytoma.
    Plouin PF; Chatellier G; Grouzmann E; Azizi M; Denolle T; Comoy E; Corvol P
    J Hypertens Suppl; 1991 Dec; 9(6):S272-3. PubMed ID: 1818966
    [No Abstract]   [Full Text] [Related]  

  • 3. Does plasma neuropeptide-Y immunoreactivity in patients with pheochromocytoma depend on hormonal activity of the tumor?
    Pruszczyk P; Wocial B; Ignatowska-Switalska H; Feltynowski T; Ellafi M; Januszewicz A; Lapiński M; Zukowska-Grojec Z; Januszewicz W
    Clin Chim Acta; 1995 Dec; 243(2):205-12. PubMed ID: 8747495
    [No Abstract]   [Full Text] [Related]  

  • 4. Rapid and reliable estimation of urinary free catecholamines in patients with pheochromocytoma: comparison with plasma catecholamines and vanillylmandelic acid excretion.
    Kremer R; Crawhall JC; Kolanitch R
    J Chromatogr; 1985 Nov; 344():313-8. PubMed ID: 4086553
    [No Abstract]   [Full Text] [Related]  

  • 5. Gene targeting through o-methylated catecholamine metabolite patterns.
    Shine B
    Clin Chem; 2011 Mar; 57(3):361-2. PubMed ID: 21245368
    [No Abstract]   [Full Text] [Related]  

  • 6. Circulating and urinary catecholamines in pheochromocytoma. Diagnostic and pathophysiologic implications.
    Bravo EL; Tarazi RC; Gifford RW; Stewart BH
    N Engl J Med; 1979 Sep; 301(13):682-6. PubMed ID: 481462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Adrenal pheochromocytoma].
    Yamada R
    Horumon To Rinsho; 1971 Jul; 19(7):579-81. PubMed ID: 4938898
    [No Abstract]   [Full Text] [Related]  

  • 8. Pheochromocytoma: rediscovery as a catecholamine-metabolizing tumor.
    Eisenhofer G; Goldstein DS; Kopin IJ; Crout JR
    Endocr Pathol; 2003; 14(3):193-212. PubMed ID: 14586065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical review 164: The laboratory diagnosis of adrenal pheochromocytoma: the Mayo Clinic experience.
    Kudva YC; Sawka AM; Young WF
    J Clin Endocrinol Metab; 2003 Oct; 88(10):4533-9. PubMed ID: 14557417
    [No Abstract]   [Full Text] [Related]  

  • 10. Advances in catecholamine and metabolite measurements for diagnosis of pheochromocytoma.
    Rosano TG; Swift TA; Hayes LW
    Clin Chem; 1991 Oct; 37(10 Pt 2):1854-67. PubMed ID: 1914202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. When is a phaeo not a phaeo? Depression in an adolescent leading to a phaeochromocytoma-like biochemical profile.
    Yeshayahu Y; Tallett S; Pacak K; De Souza C; Palmert MR
    Clin Endocrinol (Oxf); 2011 Oct; 75(4):567-8. PubMed ID: 21521331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Laboratory contribution to the diagnosis of pheochromocytoma].
    Rivero Marcotegui A; Grijalba Uche A; Palacios Sarrasqueta M; Garcia Merlo S
    An Med Interna; 1996 Jan; 13(1):40-4. PubMed ID: 8679825
    [No Abstract]   [Full Text] [Related]  

  • 13. [Analysis of catecholamines in the blood (including urinary catecholamine test): interpretation of the test results].
    Nakano Y; Sugano Y; Ezaki T; Shinbo S; Nagayama Y
    Nihon Rinsho; 1969 Mar; ():Suppl:943-9. PubMed ID: 4948303
    [No Abstract]   [Full Text] [Related]  

  • 14. [Advances in catecholamine analysis in biological samples].
    Gu Q; Shi X; Xu G
    Se Pu; 2007 Jul; 25(4):457-62. PubMed ID: 17970097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Analysis of laboratory data of 155 patients with pheochromocytoma-paraganglioma syndrome diagnosed during the past 20 years].
    Balog B; Tőke J; Róna K; Szücs N; Igaz P; Pusztai P; Sármán B; Gláz E; Kiss R; Patócs A; Rácz K; Tóth M
    Orv Hetil; 2015 Apr; 156(16):626-35. PubMed ID: 25864138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma chromogranin A + B, neuropeptide Y and catecholamines in pheochromocytoma patients.
    Gröndal S; Eriksson B; Hamberger B; Theodorsson E
    J Intern Med; 1991 May; 229(5):453-6. PubMed ID: 2040871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of urinary and plasma catecholamines using a single LC-EC system.
    Ross GA; Newbould EC; Grossman A; Perrett D
    J Pharm Biomed Anal; 1990; 8(8-12):1039-43. PubMed ID: 2100583
    [No Abstract]   [Full Text] [Related]  

  • 18. Pheochromocytoma: urinary catecholamine excretion and insulin secretion after -methyl-p-tyrosine treatment.
    Parra A; Porcayo F; Santos D
    Helv Paediatr Acta; 1972 Jul; 27(3):309-14. PubMed ID: 4645656
    [No Abstract]   [Full Text] [Related]  

  • 19. [Gastrin secretion in patients with pheochromocytoma].
    Baba M; Ichii M; Tatsuta M; Okuda S; Itoh T
    Nihon Shokakibyo Gakkai Zasshi; 1982 Oct; 79(10):1892-7. PubMed ID: 7154349
    [No Abstract]   [Full Text] [Related]  

  • 20. [The glucagon test and diagnosis of pheochromocytoma].
    von Studnitz W
    Schweiz Med Wochenschr; 1970 Jun; 100(24):1023-6. PubMed ID: 5524969
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.